About this trial
This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week "Dyadic Co-learning Intervention," which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience.
Participants will be randomly assigned to one of two groups. One group will receive regular care, while the other group will receive regular care plus the new co-learning program. The investigators will ask both patients and their spouses to complete questionnaires at the beginning of the study, and again at 10 and 16 weeks, to understand how the program affects their health and well-being.
Eligibility criteria
Qualifiers
Diagnosed with prostate cancer by a board-certified urologist.
Has either decided on a treatment plan or completed treatment within the past two years.
Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older.
Disqualifiers
Diagnosed with another type of cancer.
Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
Trial design
Treatments tested in this trial
- Dyadic Co-learning Intervention
Treatment groups
Sponsors and collaborators
National Taipei University of Nursing and Health Sciences
Lead sponsor
Chang Gung Memorial Hospital
Collaborator